Experienced bioscience entrepreneur Jeff Aronin wants to help the sick and suffering by supporting the creation of the medicines they need. For over 20 years he has been doing just that. After earning a bachelor’s degree from Northern Illinois University and graduating from DePaul University with an MBA, Aronin worked in the healthcare industry for a short while. Then in 2000 he decided to begin making his dream of producing drugs to treat rare and neglected diseases a reality. He founded Ovation Pharmaceuticals. The company focused on developing the drugs patients desperately needed.
Ovation Pharmaceuticals was a huge success. In 2009, Jeff Aronin sold the company to Dutch healthcare concern Lundbeck for $900 million. During the 10 month transition period, Aronin was Lundbeck’s CEO and president to help ensure the company would maintain its upward trajectory. Then in 2010, Jeff Aronin became president and CEO of Paragon Biosciences. The Chicago based company is a business incubator designed to help innovative biotech companies get the resources they need to recruit world-class talent and get the support they require to bring new medications to market.
Under the leadership of Jeff Aronin, Paragon Biosciences has been a leading investor in over 200 new biomedical companies focused on novel science. One of the companies that have benefitted from the work of Aronin and Paragon Biosciences is Castle Creek Pharmaceuticals, which develops medications for rare genetic dermatology conditions. Harmony Biosciences, which creates treatments for narcolepsy, cataplexy and other central nervous system disorders, is another of those companies that Paragon Biosciences is helping turn novel ideas into solutions for suffering patients.
Jeff Aronin supports a number of organizations in the Chicago community. He’s on the directorial boards of World Business Chicago and Discover Financial Services. Aronin is also actively involved with the Museum of Science and Industry, ChicagoNEXT and several other local groups. Aronin and Paragon Biosciences also participate in public/private partnerships designed to create employment opportunities in the biosciences, stimulate interest in and support for innovation by youth and people in underserved communities. Jeff Aronin is committed to improving the quality of people’s lives.